For the purposes of this notice, “press release” means this document, any oral presentation, any question-and-answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or
the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for
information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.
Takeda, Oveporexton, narcolepsy type 1, daily function, cognition, nighttime sleep, pivotal study, press release, securities law
So they cured narcolepsy or what? Sounds like hype.
Why is this “press release” thing about securities law in the article? I just want to know if Oveporexton actually helps narcolepsy type 1. Daily function and cognition… idk, my cousin’s symptoms aren’t like that.
Wait, they’re not even selling shares but the wording is all about offers and exemptions. Doesn’t that kinda mean it’s sketchy? Also “nighttime sleep” like… yeah narcolepsy literally is nighttime too right? I’m confused.
Takeda loves long documents. “Pivotal study” could mean anything honestly. The headline makes it sound like big progress for narcolepsy type 1, but then it turns into legal disclaimers about the Securities Act? Like why are we reading about registration when people just need a medicine.